Invention Grant
- Patent Title: Piperdine CXCR7 receptor modulators
-
Application No.: US16320906Application Date: 2017-07-27
-
Publication No.: US10752620B2Publication Date: 2020-08-25
- Inventor: Hamed Aissaoui , Philippe Guerry , Francois Lehembre , Julien Pothier , Laetitia Pouzol , Sylvia Richard-Bildstein , Shuguang Yuan
- Applicant: IDORSIA PHARMACEUTICALS LTD
- Applicant Address: CH Allschwil
- Assignee: IDORSIA PHARMACEUTICALS LTD.
- Current Assignee: IDORSIA PHARMACEUTICALS LTD.
- Current Assignee Address: CH Allschwil
- Agency: Culhane Meadows PLLC
- Agent Jeff B. Vockrodt
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@223875e0
- International Application: PCT/EP2017/068990 WO 20170727
- International Announcement: WO2018/019929 WO 20180201
- Main IPC: C07D413/14
- IPC: C07D413/14 ; C07D401/12 ; A61P35/00 ; C07D401/14 ; C07D413/12 ; C07D417/14
Abstract:
The present invention relates to piperidine derivatives of formula (I) wherein Ar1, Ar2, RAr1, R1, R2 and R3 are as described in the description, their preparation, to pharmaceutically acceptable salts thereof, and to their use as pharmaceuticals, to pharmaceutical compositions containing one or more compounds of formula (I), and especially to their use as CXCR7 receptor modulators.
Public/Granted literature
- US20190169180A1 PIPERDINE CXCR7 RECEPTOR MODULATORS Public/Granted day:2019-06-06
Information query
